Medicare Enrolled

Dr. Said Beydoun, M.D.

Neurology · Los Angeles, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1520 SAN PABLO ST, Los Angeles, CA 90033
3234425710
In practice since 2006 (19 years)
NPI: 1700827482 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Beydoun from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Beydoun? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Beydoun

Dr. Said Beydoun is a neurology specialist in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Beydoun performed 737 Medicare services across 355 unique beneficiaries.

Between the years covered by Open Payments, Dr. Beydoun received a total of $911,338 from 26 pharmaceutical and/or device companies across 855 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Beydoun is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 37% volume in CA $911,338 industry payments

Medicare Practice Summary

Medicare Utilization ↗
737
Medicare services
Top 37% in CA for neurology
355
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~39 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Additional hour of intravenous infusion
This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis.
199 $18 $60
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
132 $113 $535
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
118 $72 $400
Limited needle EMG of arm or leg muscles
A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area.
80 $14 $45
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
68 $59 $210
New patient office visit, complex (60-74 min) 52 $142 $750
Nerve conduction studies, 13 or more
A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed.
26 $150 $645
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
23 $51 $275
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
21 $39 $110
Nerve conduction studies, 11-12
A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies.
18 $115 $545
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
36.2% high complexity
10.9% medium
52.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$911,338
Total received (2018-2024)
Avg $130,191/year across 7 years
Top 1% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
855
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$756,567 (83.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$153,562 (16.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,210 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$197,381
2023
$161,380
2022
$118,159
2021
$57,535
2020
$91,614
2019
$166,804
2018
$118,465

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Takeda Pharmaceuticals U.S.A., Inc.
$39,857
Alexion Pharmaceuticals, Inc.
$38,989
UCB, Inc.
$37,036
ARGENX US, INC.
$29,564
AstraZeneca Pharmaceuticals LP
$18,163
Alnylam Pharmaceuticals Inc.
$9,336
Amgen Inc.
$8,976
CSL Behring
$5,185
Janssen Global Services, LLC
$4,744
Grifols USA, LLC
$2,299
Janssen Scientific Affairs, LLC
$1,090
Amylyx Pharmaceuticals, Inc.
$1,050
Octapharma USA, Inc.
$1,000
GENZYME CORPORATION
$92
Top 3 companies account for 58.7% of 2024 payments
All-time payments by company (2018-2024) ›
CSL Behring
$155,554
Alexion Pharmaceuticals, Inc.
$152,684
Takeda Pharmaceuticals U.S.A., Inc.
$95,184
Alnylam Pharmaceuticals Inc.
$89,745
Akcea Therapeutics, Inc.
$79,539
ARGENX US, INC.
$70,680
UCB, Inc.
$68,201
Mitsubishi Tanabe Pharma America, Inc.
$48,162
Shire North American Group Inc
$37,035
Grifols USA, LLC
$25,975
AstraZeneca Pharmaceuticals LP
$22,676
Amylyx Pharmaceuticals, Inc.
$16,445
MITSUBISHI TANABE PHARMA AMERICA, INC.
$9,075
Amgen Inc.
$8,976
Biogen, Inc.
$8,267
Janssen Global Services, LLC
$8,044
Octapharma USA, Inc.
$4,842
Genentech, Inc.
$3,856
CATALYST PHARMACEUTICALS, INC.
$2,500
PFIZER INC.
$2,100
Janssen Scientific Affairs, LLC
$1,090
Grifols Shared Services North America, Inc.
$494
GENZYME CORPORATION
$92
ACADIA Pharmaceuticals Inc
$60
SANOFI-AVENTIS U.S. LLC
$59
Travere Therapeutics, Inc.
$4
Top 3 companies account for 44.3% of all-time payments
Associated products mentioned in payments ›
AMVUTTRA · Cholbam · EXSERVAN · Enspryng · Evrysdi · FIRDAPSE · GAMMAGARD · GAMMAGARD LIQUID · Gamunex-C · HYQVIA · Hizentra · KRYSTEXXA · NUPLAZID · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · PANZYGA · Privigen · RADICAVA · RELYVRIO · Radicava · Rystiggo · SOLIRIS · SPINRAZA · Soliris · TEGSEDI · ULTOMIRIS · UPLIZNA · VYVGART · VYVGART HYTRULO · WAINUA · Xembify · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (83%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for neurology in CA.

Looking for a neurology specialist in Los Angeles?
Compare neurologists in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
578
Per 100K population
5.9
County median income
$87,760
Nearest hospital
ADVENTIST HEALTH WHITE MEMORIAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Beydoun is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Beydoun experienced with additional hour of intravenous infusion?
Based on Medicare claims data, Dr. Beydoun performed 199 additional hour of intravenous infusion services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Beydoun receive payments from pharmaceutical companies?
Yes. Dr. Beydoun received a total of $911,338 from 26 companies across 855 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Beydoun's costs compare to other neurologists in Los Angeles?
Dr. Beydoun's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Beydoun) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →